Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 10/2018

01-10-2018 | Correction

Correction to: Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus

Authors: Hui Ning, Hong Tao, Zhanping Weng, Xingbo Zhao

Published in: Acta Diabetologica | Issue 10/2018

Login to get access

Excerpt

The title “Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus” should be replaced by “Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus”. …
Metadata
Title
Correction to: Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus
Authors
Hui Ning
Hong Tao
Zhanping Weng
Xingbo Zhao
Publication date
01-10-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 10/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1177-0

Other articles of this Issue 10/2018

Acta Diabetologica 10/2018 Go to the issue

Original Article

Maternal gestational diabetes mellitus and the risk of subsequent pediatric cardiovascular diseases of the offspring: a population-based cohort study with up to 18 years of follow up

Correction

Correction to: The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial

Original Article

FRAX tool in type 2 diabetic subjects: the use of HbA1c in estimating fracture risk

Original Article

Assessment of glucose effectiveness from short IVGTT in individuals with different degrees of glucose tolerance

Short Communication

Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function

Original Article

Glucose regulation and physical performance among older people: the Helsinki Birth Cohort Study

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits